questionsmedicales.fr
Technologie, industrie et agriculture
Produits manufacturés
Dispositifs pour fumer
Produits du tabac
Produits du tabac : Questions médicales fréquentes
Termes MeSH sélectionnés :
Leukocyte L1 Antigen Complex
Diagnostic
2
Dépendance au tabac
Diagnostic médical
Tests de fonction pulmonaire
Tabagisme
Symptômes
2
Intoxication au tabac
Symptômes
Tabagisme
Maladies respiratoires
Prévention
2
Prévention du tabagisme
Éducation à la santé
Législation anti-tabac
Santé publique
Traitements
2
Sevrage tabagique
Traitement médicamenteux
Thérapie comportementale
Dépendance au tabac
Complications
2
Complications du tabagisme
Maladies cardiovasculaires
Cancer du poumon
Tabagisme
Facteurs de risque
2
Facteurs de risque
Tabagisme
Stress
Dépendance au tabac
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Produits du tabac : Questions médicales les plus fréquentes",
"headline": "Produits du tabac : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Produits du tabac : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-18",
"dateModified": "2025-02-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Produits du tabac"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Dispositifs pour fumer",
"url": "https://questionsmedicales.fr/mesh/D000074602",
"about": {
"@type": "MedicalCondition",
"name": "Dispositifs pour fumer",
"code": {
"@type": "MedicalCode",
"code": "D000074602",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.767"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tabac sans fumée",
"alternateName": "Tobacco, Smokeless",
"url": "https://questionsmedicales.fr/mesh/D014030",
"about": {
"@type": "MedicalCondition",
"name": "Tabac sans fumée",
"code": {
"@type": "MedicalCode",
"code": "D014030",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.767.844.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tabac pour pipe à eau",
"alternateName": "Tobacco, Waterpipe",
"url": "https://questionsmedicales.fr/mesh/D000073846",
"about": {
"@type": "MedicalCondition",
"name": "Tabac pour pipe à eau",
"code": {
"@type": "MedicalCode",
"code": "D000073846",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.767.844.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Produits du tabac",
"alternateName": "Tobacco Products",
"code": {
"@type": "MedicalCode",
"code": "D062789",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Takahiro Tabuchi",
"url": "https://questionsmedicales.fr/author/Takahiro%20Tabuchi",
"affiliation": {
"@type": "Organization",
"name": "Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, Japan."
}
},
{
"@type": "Person",
"name": "Jennifer B Unger",
"url": "https://questionsmedicales.fr/author/Jennifer%20B%20Unger",
"affiliation": {
"@type": "Organization",
"name": "Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America."
}
},
{
"@type": "Person",
"name": "Pamela M Ling",
"url": "https://questionsmedicales.fr/author/Pamela%20M%20Ling",
"affiliation": {
"@type": "Organization",
"name": "Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, California."
}
},
{
"@type": "Person",
"name": "Silvano Gallus",
"url": "https://questionsmedicales.fr/author/Silvano%20Gallus",
"affiliation": {
"@type": "Organization",
"name": "Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy."
}
},
{
"@type": "Person",
"name": "Jessica L Barrington-Trimis",
"url": "https://questionsmedicales.fr/author/Jessica%20L%20Barrington-Trimis",
"affiliation": {
"@type": "Organization",
"name": "Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America. Electronic address: jtrimis@usc.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Association of Human Leukocyte Antigens Complex with Type 1 Diabetes in the Omani Population.",
"datePublished": "2023-02-23",
"url": "https://questionsmedicales.fr/article/36865417",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.18295/squmj.2.2022.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "New insights on the role of human leukocyte antigen complex in primary biliary cholangitis.",
"datePublished": "2022-08-31",
"url": "https://questionsmedicales.fr/article/36119102",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.975115"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human leukocyte antigen and tumor immunotherapy (Review).",
"datePublished": "2023-04-28",
"url": "https://questionsmedicales.fr/article/37114561",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3892/ijo.2023.5516"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human leukocyte antigen-G in gynaecological tumours.",
"datePublished": "2023-07-06",
"url": "https://questionsmedicales.fr/article/37415092",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/iji.12626"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prediction of KIR3DL1/Human Leukocyte Antigen binding.",
"datePublished": "2024-05-05",
"url": "https://questionsmedicales.fr/article/38746109",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1101/2024.05.03.592082"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Technologie, industrie et agriculture",
"item": "https://questionsmedicales.fr/mesh/D013676"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits manufacturés",
"item": "https://questionsmedicales.fr/mesh/D008420"
},
{
"@type": "ListItem",
"position": 4,
"name": "Dispositifs pour fumer",
"item": "https://questionsmedicales.fr/mesh/D000074602"
},
{
"@type": "ListItem",
"position": 5,
"name": "Produits du tabac",
"item": "https://questionsmedicales.fr/mesh/D062789"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Produits du tabac - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Produits du tabac",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Produits du tabac",
"description": "Comment diagnostiquer une dépendance au tabac ?\nQuels tests pour évaluer les effets du tabac ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Leukocyte+L1+Antigen+Complex#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Produits du tabac",
"description": "Quels sont les symptômes d'une intoxication au tabac ?\nComment le tabac affecte-t-il la respiration ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Leukocyte+L1+Antigen+Complex#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Produits du tabac",
"description": "Comment prévenir le tabagisme chez les jeunes ?\nLes lois anti-tabac sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Leukocyte+L1+Antigen+Complex#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Produits du tabac",
"description": "Quels traitements existent pour arrêter de fumer ?\nLes thérapies comportementales sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Leukocyte+L1+Antigen+Complex#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Produits du tabac",
"description": "Quelles sont les complications du tabagisme ?\nLe tabac augmente-t-il le risque de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Leukocyte+L1+Antigen+Complex#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Produits du tabac",
"description": "Quels sont les facteurs de risque du tabagisme ?\nLe stress influence-t-il la consommation de tabac ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Leukocyte+L1+Antigen+Complex#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dépendance au tabac ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des questionnaires d'auto-évaluation et l'observation des symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer les effets du tabac ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets du tabac."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication au tabac ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent nausées, vertiges, maux de tête et palpitations cardiaques."
}
},
{
"@type": "Question",
"name": "Comment le tabac affecte-t-il la respiration ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabac provoque une toux chronique, un essoufflement et une diminution de la capacité pulmonaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir le tabagisme chez les jeunes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation, les campagnes de sensibilisation et les politiques anti-tabac sont essentielles."
}
},
{
"@type": "Question",
"name": "Les lois anti-tabac sont-elles efficaces ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles réduisent la consommation de tabac et protègent les non-fumeurs de l'exposition."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour arrêter de fumer ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les substituts nicotiniques, les médicaments et la thérapie comportementale."
}
},
{
"@type": "Question",
"name": "Les thérapies comportementales sont-elles efficaces ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles augmentent les chances d'arrêter de fumer en modifiant les comportements liés au tabagisme."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du tabagisme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent le cancer, les maladies cardiovasculaires et les maladies respiratoires chroniques."
}
},
{
"@type": "Question",
"name": "Le tabac augmente-t-il le risque de cancer ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabac est un facteur de risque majeur pour plusieurs types de cancer, notamment le poumon."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du tabagisme ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, l'environnement social, et l'exposition à des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la consommation de tabac ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut augmenter la consommation de tabac chez les individus dépendants."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 12/02/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, Japan.
Publications dans "Produits du tabac" :
4 publications dans cette catégorie
Affiliations :
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America.
Publications dans "Produits du tabac" :
4 publications dans cette catégorie
Affiliations :
Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, California.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America. Electronic address: jtrimis@usc.edu.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, California, USA.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
RAND Corporation, Pittsburgh, PA, USA.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
RAND Corporation, Santa Monica, CA, USA.
Publications dans "Produits du tabac" :
3 publications dans cette catégorie
Affiliations :
National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy.
School of Medicine, University Vita-Salute San Raffaele, 20132 Milan, Italy.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Department of Epidemiology, CAPHRI-School for Public Health and Primary Care, Maastricht University Medical Centre, 6211 LK Maastricht, The Netherlands.
Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, 6211 LK Maastricht, The Netherlands.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Oncologic Network, Prevention and Research Institute (ISPRO), 50139 Florence, Italy.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, Japan.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Department of Environmental Medicine, University of Rochester Medical Center, Rochester, United States.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America.
Publications dans "Produits du tabac" :
2 publications dans cette catégorie
Affiliations :
Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America.
Publications dans "Produits du tabac" :
Identification of the high risk alleles, genotypes and haplotypes of the human leukocyte antigens (HLA) in different populations is beneficial for understanding their roles in type 1 diabetes (T1D) pa...
The present case-control study included 73 diabetic seropositive children (mean age 9.08 ± 3.27 years) attending the paediatric clinic at Sultan Qaboos University Hospital in Muscat, Oman, and 110 hea...
Two HLA class I alleles (...
Known HLA class II gene alleles are associated with T1D in Omani children....
Primary Biliary Cholangitis (PBC) is a rare autoimmune cholangiopathy. Genetic studies have shown that the strongest statistical association with PBC has been mapped in the human leukocyte antigen (HL...
Malignant tumors seriously endanger human health and life, and restrict economic development. Human leukocyte antigen (HLA) is the expression product of the human major histocompatibility complex, whi...
Gynaecological tumours that threaten the health of women, especially when advanced and recurrent, have remained mostly intractable to existing treatments. Therefore, new therapeutic targets are urgent...
KIR3DL1 is a polymorphic inhibitory Natural Killer (NK) cell receptor that recognizes Human Leukocyte Antigen (HLA) class I allotypes that contain the Bw4 motif. Structural analyses have shown that in...
The aim of this study was to determine the Human Leukocyte Antigen (HLA) class II (...
Despite recent scientific inquiry, idiopathic subglottic stenosis (iSGS) remains an enigmatic disease. The consistent demographics of the affected population suggest genetic factors may contribute to ...
High-resolution HLA typing of 37 iSGS patients was compared with 1,242,890 healthy Caucasian controls of European ancestry from the USA National Marrow Donor Program and 281 patients with granulomatos...
Complete HLA genotyping of an iSGS population showed no significant associations when compared to a North American Caucasian control population. Unlike GPA patients, iSGS was not associated with allel...
There was not a detectable HLA association observed in iSGS. These results support the concept that iSGS possesses a distinct genetic architecture from GPA. If genetic susceptibility exists in iSGS, i...
NA, basic science Laryngoscope, 133:2533-2539, 2023....
Kaposi sarcoma, caused by the pathogen Kaposi sarcoma-associated herpesvirus (KSHV), is the most common neoplasm for patients with AIDS. Susceptibility to KSHV has been associated with several differe...
A case-control study was performed in Xinjiang, a KSHV-endemic region of China. We recruited 299 individuals with HIV, including 123 KSHV-seropositive persons and 176 KSHV-seronegative controls. We us...
This study provides further insight into the link between...
Dengue fever (DF) is a disease caused by dengue virus (DENV) from the family Flaviviridae. The role of human leukocyte antigens (HLAs) in dengue fever (DF) and its more severe manifestation, dengue he...
A meta-analysis on DHF and DF susceptibility in patients with HLA-A*24 and HLA-B*44 was conducted. Google Scholar was used to find studies that contained patients with HLA-A*24 or HLA-B*44 that were d...
HLA-A*24 was associated with a 1.39 times susceptibility to DHF while those possessing HLA-B*44 were 0.62 times susceptible to DHF (OR=1.39 and 95% CI=1.17-1.66; OR=0.62 and 95% CI=0.39-0.99). Neither...
These results indicate that two different major histocompatibility complex (MHC) class I alleles, HLA-A*24 and HLA-B*44, have opposing effects on DHF susceptibility but none on DF susceptibility. The ...
Antibody-mediated rejection (AMR) is the most common cause of immune-mediated allograft failure after kidney transplant and impacts allograft survival. Previous sensitization is a major risk factor fo...
A 48-year-old, caucasian woman with end-stage kidney disease (ESKD) secondary to autosomal dominant polycystic kidney disease (ADPKD) on peritoneal dialysis was registered in deceased donor waitlist. ...
Shared eplets between the patient husband and donor was responsible for the alloimmune response and early development of DSAs. This case highlights the importance of early monitoring DSA levels in hig...